← Oncology Approval Tracker

FDA DECISION ·

Pomalyst

pomalidomide · Celgene

Accelerated approvalNew or expanded indicationKaposi sarcoma
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

Adults with AIDS-related Kaposi sarcoma after failure of highly active antiretroviral therapy, or Kaposi sarcoma in adults without HIV.

LAMPGEN ANALYSIS

Why it matters

Added an oral option for two Kaposi sarcoma populations under accelerated approval.

What research teams should watch

Coordinate HIV history and prior antiretroviral therapy documentation with protocol-required safety checks.

PRIMARY RECORDS

Sources